Synthetic, Self Adjuvanting Vaccines
The present invention relates generally to the field of immunotherapy, and more particularly to immunomedicaments in the form of lipopeptides which induce an antibody response to drugs of dependence, and uses thereof in the treatment and prevention of drug addiction.
Attached files:Patents:US 20,100,266,623
Inventor(s):
JACKSON DAVID CHARLES [AU]; ZENG WEIGUANG [AU]; KINSEY BERMA [US]
Type of Offer:
Sale
« More Life Sciences Patents